Análisis del mercado de biosimulación y sus ingresos hasta 2029</font></font>

Name: Mercado de biosimulación por producto (software, simulación molecular, servicios internos, servicios por contrato), aplicación (ensayos clínicos, PKPD, ADME), entrega (suscripción, propiedad), usuario final (biotecnología, compañías farmacéuticas, CRO, normativas) y por región (América del Norte, América Latina, Europa, Asia Pacífico y Oriente Medio y África), tendencias globales y pronóstico de 2022 a 2029
Price: 3499 USD
Availability: InStock
Rating: 4.5 (94 reviews)
Author: Exactitude Consultancy
ISBN: 11859

Panorama del mercado de la biosimulación

El tamaño del mercado de biosimulación se valoró en USD 2.21 mil millones en 2020 y se proyecta que alcance los USD 8.27 mil millones para 2029, creciendo a una CAGR del 15,8% entre 2022 y 2029.

En el campo de la investigación de fármacos , la biosimulación es cada vez más importante. La biosimulación puede utilizarse para predecir si un posible fármaco fracasará en el proceso de desarrollo, como los ensayos clínicos , debido a efectos secundarios indeseables, una farmacocinética deficiente o incluso toxicidad, dado que solo el 11% de todos los fármacos candidatos son aprobados. La predicción temprana de si un medicamento fracasará en animales o en personas sería fundamental para reducir los gastos de desarrollo de fármacos, así como el número de pruebas con animales y ensayos clínicos necesarios. La biosimulación se centra en proporcionar predicciones basadas en modelos del comportamiento y la dinámica de los sistemas biológicos . El enorme aumento del gasto en I+D de las empresas farmacéuticas y biotecnológicas puede atribuirse a la expansión del mercado mundial de la biosimulación. Además, el elevado coste de volver a realizar los ensayos clínicos como resultado de la alta tasa de fracasos en los ensayos clínicos de fase III fomenta el uso de la biosimulación en el descubrimiento y desarrollo de fármacos, lo que promueve el crecimiento del mercado.

Durante las últimas décadas, se han producido grandes avances en varios sectores de la industria médica como resultado de los avances tecnológicos y las actividades de investigación. En los últimos años, el desarrollo de tratamientos innovadores para diversas enfermedades y trastornos médicos ha cambiado de rumbo, lo que ha dado lugar a una demanda sin precedentes de biosimulación, un factor que se prevé que impulse el crecimiento del mercado de la biosimulación durante el período de evaluación. La biosimulación se utiliza en el descubrimiento y desarrollo de fármacos para diversos fines, entre los que se incluyen la identificación y validación de objetivos, la optimización de los fármacos y las pruebas preclínicas de nuevos fármacos.

ATRIBUTO	DETALLES
Periodo de estudio	2020-2029
Año base	2021
Año estimado	2022
Año pronosticado	2022-2029
Periodo histórico	2018-2020
Unidad	Valor (miles de millones de USD)
Segmentación	Por producto, por aplicación, por entrega, por usuario final y por región
Por producto	Software Simulación molecular En casa Servicios por contrato
Por aplicación	Ensayos clínicos Policía de KPK AdmE
Por entrega	Suscripción Propiedad
Por el usuario final	Biotecnología Compañías farmacéuticas Cros Regulatory
By Region	North America Asia Pacific Europe South America Middle East Asia & Africa

The recording, annotation, storage, analysis, and retrieval of nucleic acid sequence, protein sequence, and structural information are all covered by biosimulation. It has a variety of uses in health and biology, including molecular medications, preventive medicine, gene therapy, drug development, biotechnology, and microbial forensic investigation. It's also employed in genetics and genomic research. The global biosimulation market is predicted to develop significantly in the near future, owing to an increase in demand for integrated data, a rise in demand for nucleic acid and protein sequencing due to lower sequencing costs, and an increase in proteomics and genomics applications. Moreover, drug research and development, as well as government and private-sector activities, are likely to drive market expansion over the projection period. The demand for integrated biosimulation systems in proteomics and genomics is also driving the biosimulation market forward.

A new drug's development requires a significant quantity of research and resources. Every stage of the medication development process, from clinical trials through approval, has a significant risk of failure. Biosimulation can considerably lower these odds. Biosimulation not only aids in the prediction of medication failure throughout the development phase, but it also lowers the expense of any other potential failures by reducing the number of clinical trials required. Pharmaceutical companies (such as Pfizer, Merck, Novartis, and Johnson Pharmaceutical Research & Development) and research firms (such as Johnson Pharmaceutical Research & Development) have been using biosimulation software and service providers to reduce the length of trials and the high costs associated with failures.

Furthermore, the market's growth is expected to be fueled by the clinical urgency to produce high-potency and sophisticated medications. Biosimulation is being more widely used in disease simulation modelling, such as diabetes mellitus. Models for advanced therapies are developed using it in conjunction with proteomic and genomic technology. As a result of ongoing technology developments and software upgrades, researchers' interest in biosimulation is projected to expand. This is expected to provide the market a significant lift. Technical advancements include microarrays and prediction models, to name a few. Semantic systems that enable a restricted number of biosimulation elements have also been developed, decreasing the time, cost, and complexity of the entire process.

La biosimulación captura y procesa diversos aspectos de los procesos biológicos utilizando una variedad de modelos, herramientas y lenguajes. Los métodos de modelado actuales no logran capturar la semántica fundamental de los modelos de biosimulación, lo que dificulta la construcción, reutilización, composición y fusión de modelos de biosimulación diversos y complicados. El uso de tecnología in silico o de biosimulación en el proceso de investigación o desarrollo de medicamentos aún no ha sido estandarizado por las agencias reguladoras. La capacidad de cómputo de los investigadores biomédicos para construir y operar sistemas de biosimulación sofisticados ha aumentado como resultado de los recientes desarrollos tecnológicos. Por otro lado, los investigadores encuentran más difícil comunicar, administrar y cambiar sus modelos a medida que sus modelos y simulaciones se vuelven más complicados. La falta de estándares escalables para la representación y reutilización de modelos exacerba el desafío de compartir modelos biomédicos sofisticados. Como resultado, muchos desarrolladores de modelos no pueden intercambiar y construir nuevos modelos basados en modelos existentes. Esta debilidad de la biosimulación solo se puede abordar mediante el desarrollo de un modelo de representación sistemático basado en estándares que pueda expresar de manera inequívoca los datos de biosimulación en formatos legibles tanto para humanos como para máquinas. Como resultado, la comunidad de biosimulación necesita desesperadamente herramientas que les ayuden a construir, gestionar y reutilizar sus modelos de forma más eficiente.

[título id="attachment_11860" align="alignleft" width="870"]

Biosimulation Market | Exactitude Consultancy

Mercado de biosimulación | Exactitude Consultancy[/subtítulo]

Frequently Asked Questions

• What is the worth of Biosimulation market?

Biosimulation market size was valued at USD 2.21 billion in 2020 and is projected to reach USD 8.27 billion by 2029, growing at a CAGR of 15.8% from 2022 to 2029.

• What is the size of the North America Biosimulation market industry?

North America held more than 44% of the Biosimulation market revenue share in 2021 and will witness expansion in the forecast period.

• What are some of the market's driving forces?

In recent years, the development of breakthrough treatments for a number of medical diseases and disorders has shifted gears, resulting in unprecedented demand for biosimulation– a factor that is projected to boost the biosimulation market's growth during the assessment period. Biosimulation is utilised in drug discovery and development for a variety of purposes, including target identification and validation, lead optimization, and pre-clinical testing of new drugs.

• Which are the top companies to hold the market share in Biosimulation market?

Certara, Simulations Plus Inc, Dassault Systèmes, Schrödinger, ACD/Labs, Chemical Computing Group, Physiomics, Evidera, InSilico Biosciences, INOSIM Software, Insilico Biotechnology, LeadInvent Technologies, Rosa, Nuventra Pharma, and Genedata are some of the major players in the market that are dominating the market

• What is the leading application of Biosimulation market?

The leading application of Biosimulation market in 2020 was pharmaceutical market segment. It has the biggest market share.

• Which is the largest regional market for Biosimulation market?

North America held the largest market share of Biosimulation market.

Biosimulation Market Segment Analysis

The market is broadly segmented into product, application, delivery, end user and region. Based on product & service, the biosimulation market is segmented into software and services. The biosimulation software segment is expected to account for the largest market share. The increasing usage of biosimulation software by pharmaceutical and research firms, as well as increased R&D investment for pharmaceutical research, are driving this segment's rapid rise.

Based on end user, research institutes, pharmaceutical and biotechnology businesses, contract research organisations (CROs), regulatory authorities, and other end users make up the biosimulation market (consulting firms, defence research and development organizations, nutraceutical companies, and food and agricultural companies). Pharmaceutical and biotechnology firms are likely to account for the greatest share, with the highest CAGR throughout the forecast period. Increased pharmaceutical and biotechnology R&D spending, as well as increased adoption of inorganic development strategies by various biosimulation service providers, are expected to drive biosimulation solutions adoption in the pharmaceutical and biotechnology industries.

[caption id="attachment_11861" align="alignleft" width="680"]

Biosimulation Market | Exactitude Consultancy[/caption]

Biosimulation Market Players

Certara, Simulations Plus Inc, Dassault Systèmes, Schrödinger, ACD/Labs, Chemical Computing Group, Physiomics, Evidera, InSilico Biosciences, INOSIM Software, Insilico Biotechnology, LeadInvent Technologies, Rosa, Nuventra Pharma, and Genedata are some of the major players in the market that are dominating the market.

Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modelling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries.
Dassault Systèmes SE is a French software corporation, which develops software for 3D product design, simulation, manufacturing and other 3D related products.

Who Should Buy? Or Key Stakeholders

Software Industry
Pharmaceutical Industry
Healthcare Industry
Biotechnology Companies
Hospitals and Clinics
Scientific Research and Development
Investors
Manufacturing companies
End user companies

Biosimulation Market Regional Analysis

The global biosimulation market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

With a market share of 44 percent in 2021, North America dominated the biosimulation market. Growth in the biotechnology and pharmaceutical industries, a significant number of active drug development processes, growing usage of personalised medicine, and higher R&D expenditure by pharmaceutical and biotechnology businesses are all contributing to the North American market's dominance.

[caption id="attachment_11862" align="alignleft" width="680"]

Biosimulation Market | Exactitude Consultancy[/caption]

Key Market Segments: Biosimulation Market

Biosimulation Market by Product, 2020-2029, (USD Million)

Software
Molecular Simulation
In House
Contract Services

Biosimulation Market by Application, 2020-2029, (USD MILLION)

Clinical Trials
PKPD
ADME

Biosimulation Market by Delivery, 2020-2029, (USD Million)

Subscription
Ownership

Biosimulation Market by End User, 2020-2029, (USD MILLION)

BIOTECH
PHARMA COMPANIES
CROS
REGULATORY

Biosimulation Market By Region, 2020-2029, (USD MILLION)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered.

[video width="1920" height="1080" mp4="https://gwsdigital.com/exactitudeconsultancy/wp-content/uploads/2022/11/Biosimulation-Market-.mp4" poster="https://gwsdigital.com/exactitudeconsultancy/wp-content/uploads/2022/02/exactitude-1-3.jpg"][/video]

INTRODUCCIÓN
1. DEFINICIÓN DE MERCADO
2. SEGMENTACIÓN DEL MERCADO
3. CRONOGRAMAS DE INVESTIGACIÓN
4. SUPUESTOS Y LIMITACIONES

METODOLOGÍA DE LA INVESTIGACIÓN
1. MINERÍA DE DATOS
  1. INVESTIGACIÓN SECUNDARIA
  2. INVESTIGACIÓN PRIMARIA
  3. ASESORAMIENTO DE EXPERTOS EN LA MATERIA
2. CONTROLES DE CALIDAD
  1. REVISIÓN FINAL
3. TRIANGULACIÓN DE DATOS
  1. ENFOQUE DE ABAJO HACIA ARRIBA
  2. ENFOQUE DE ARRIBA HACIA ABAJO
  3. FLUJO DE INVESTIGACIÓN
4. FUENTES DE DATOS

RESUMEN EJECUTIVO

PANORAMA DEL MERCADO
1. PERSPECTIVAS DEL MERCADO GLOBAL DE BIOSIMULACIÓN
  1. IMPULSORES DEL MERCADO
  2. RESTRICCIONES DEL MERCADO
  3. OPORTUNIDADES DE MERCADO
2. IMPACTO DEL COVID-19 EN EL MERCADO GLOBAL DE BIOSIMULACIÓN

MERCADO GLOBAL DE BIOSIMULACIÓN POR PRODUCTO (MILLONES DE USD)
1. SOFTWARE
2. SIMULACIÓN MOLECULAR
3. EN CASA
4. SERVICIOS CONTRACTUALES

MERCADO GLOBAL DE BIOSIMULACIÓN POR ENTREGA (MILLONES DE USD)
1. SUSCRIPCIÓN
2. PROPIEDAD

MERCADO GLOBAL DE BIOSIMULACIÓN POR APLICACIÓN (MILLONES DE USD)
1. ENSAYOS CLÍNICOS
2. Policía de KPK
3. AdmE

MERCADO GLOBAL DE BIOSIMULACIÓN POR USUARIO FINAL (MILLONES DE USD)
1. BIOTECNOLOGÍA
2. EMPRESAS FARMACÉUTICAS
3. Cruz
4. REGULADOR

MERCADO GLOBAL DE BIOSIMULACIÓN POR REGIÓN (MILLONES DE USD)
1. INTRODUCCIÓN
2. ASIA-PACÍFICO
  1. PORCELANA
  2. INDIA
  3. JAPÓN
  4. COREA DEL SUR
  5. AUSTRALIA
  6. ASIA SUDESTE
  7. RESTO DE ASIA-PACÍFICO
3. AMÉRICA DEL NORTE
  1. ESTADOS UNIDOS
  2. CANADÁ
  3. MÉXICO
4. EUROPA
  1. ALEMANIA
  2. REINO UNIDO
  3. FRANCIA
  4. ITALIA
  5. ESPAÑA
  6. RUSIA
  7. RESTO DE EUROPA
5. SUDAMERICA
  1. BRASIL
  2. ARGENTINA
  3. COLOMBIA
  4. RESTO DE SUDAMÉRICA
6. ORIENTE MEDIO Y ÁFRICA
  1. Emiratos Árabes Unidos
  2. ARABIA SAUDITA
  3. SUDÁFRICA
  4. RESTO DE ORIENTE MEDIO Y ÁFRICA

PERFILES DE EMPRESAS* (DESCRIPCIÓN GENERAL DEL NEGOCIO, RESEÑA DE LA EMPRESA, PRODUCTOS OFRECIDOS, DESARROLLOS RECIENTES)

1. CERTARA
2. SIMULACIONES PLUS INC
3. SISTEMAS DASSAULT
4. Schrödinger
5. ACD/LABORATORIOS
6. GRUPO DE COMPUTACION QUIMICA
7. FISIOMIA
8. EVIDERA
9. INSILICO BIOSCIENCES
10. INOSIM SOFTWARE
11. INSILICO BIOTECHNOLOGY
12. OTHERS *THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS)2020-2029

TABLE 2 GLOBAL BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 3 GLOBAL BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 4 GLOBAL BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 5 GLOBAL BIOSIMULATION MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 6 US BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 7 US BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 8 US BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 9 US BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 10              CANADA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 11              CANADA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 12              CANADA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 13              CANADA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 14              MEXICO BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 15              MEXICO BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 16              MEXICO BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 17              MEXICO BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 18              BRAZIL BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 19              BRAZIL BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 20              BRAZIL BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 21              BRAZIL BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 22              ARGENTINA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 23              ARGENTINA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 24              ARGENTINA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 25              ARGENTINA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 26              COLOMBIA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 27              COLOMBIA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 28              COLOMBIA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 29              COLOMBIA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 30              REST OF SOUTH AMERICA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 31              REST OF SOUTH AMERICA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 32              REST OF SOUTH AMERICA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 33              REST OF SOUTH AMERICA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 34              INDIA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 35              INDIA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 36              INDIA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 37              INDIA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 38              CHINA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 39              CHINA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 40              CHINA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 41              CHINA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 42              JAPAN BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 43              JAPAN BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 44              JAPAN BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 45              JAPAN BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 46              SOUTH KOREA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 47              SOUTH KOREA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 48              SOUTH KOREA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 49              SOUTH KOREA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 50              AUSTRALIA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 51              AUSTRALIA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 52              AUSTRALIA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 53              AUSTRALIA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 54              SOUTH-EAST ASIA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 55              SOUTH-EAST ASIA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 56              SOUTH-EAST ASIA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 57              SOUTH-EAST ASIA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 58              REST OF ASIA PACIFIC BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 59              REST OF ASIA PACIFIC BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 60              REST OF ASIA PACIFIC BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 61              REST OF ASIA PACIFIC BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 62              GERMANY BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 63              GERMANY BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 64              GERMANY BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 65              GERMANY BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 66              UK BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 67              UK BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 68              UK BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 69              UK BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 70              FRANCE BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 71              FRANCE BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 72              FRANCE BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 73              FRANCE BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 74              ITALY BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 75              ITALY BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 76              ITALY BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 77              ITALY BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 78              SPAIN BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 79              SPAIN BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 80              SPAIN BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 81              SPAIN BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 82              RUSSIA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 83              RUSSIA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 84              RUSSIA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 85              RUSSIA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 86              REST OF EUROPE BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 87              REST OF EUROPE BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 88              REST OF EUROPE BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 89              REST OF EUROPE BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 90              UAE BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 91              UAE BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 92              UAE BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 93              UAE BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 94              SAUDI ARABIA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 95              SAUDI ARABIA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 96              SAUDI ARABIA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 97              SAUDI ARABIA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 98              SOUTH AFRICA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 99              SOUTH AFRICA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 100            SOUTH AFRICA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 101            SOUTH AFRICA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

TABLE 102            REST OF MIDDLE EAST AND AFRICA BIOSIMULATION MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 103            REST OF MIDDLE EAST AND AFRICA BIOSIMULATION MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 104            REST OF MIDDLE EAST AND AFRICA BIOSIMULATION MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 105            REST OF MIDDLE EAST AND AFRICA BIOSIMULATION MARKET BY DELIVERY (USD MILLIONS) 2020-2029

LIST OF FIGURES

FIGURE 1       MARKET DYNAMICS

FIGURE 2       MARKET SEGMENTATION

FIGURE 3       REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4       DATA TRIANGULATION

FIGURE 5       BOTTOM-UP APPROACH

FIGURE 6       TOP-DOWN APPROACH

FIGURE 7       RESEARCH FLOW

FIGURE 8       GLOBAL BIOSIMULATION MARKET BY PRODUCT, USD MILLION, 2020-2029

FIGURE 10    GLOBAL BIOSIMULATION MARKET BY DELIVERY, USD MILLION, 2020-2029

FIGURE 11    GLOBAL BIOSIMULATION MARKET BY APPLICATION, USD MILLION, 2020-2029

FIGURE 12    GLOBAL BIOSIMULATION MARKET BY END USER, USD MILLION, 2020-2029

FIGURE 13    GLOBAL BIOSIMULATION MARKETBY REGION, USD MILLION, 2020-2029

FIGURE 14    PORTER’S FIVE FORCES MODEL

FIGURE 15    GLOBAL BIOSIMULATION MARKETBY PRODUCT, 2020

FIGURE 16    GLOBAL BIOSIMULATION MARKETBY DELIVERY 2020

FIGURE 17    GLOBAL BIOSIMULATION MARKETBY APPLICATION 2020

FIGURE 18    GLOBAL BIOSIMULATION MARKET BY END USER 2020

FIGURE 19    BIOSIMULATION MARKETBY REGION 2020

FIGURE 20    MARKET SHARE ANALYSIS

FIGURE 21    CERTARA: COMPANY SNAPSHOT

FIGURE 22    SIMULATIONS PLUS INC: COMPANY SNAPSHOT

FIGURE 23    DASSAULT SYSTÈMES: COMPANY SNAPSHOT

FIGURE 24    SCHRÖDINGER: COMPANY SNAPSHOT

FIGURE 25    ACD/LABS: COMPANY SNAPSHOT

FIGURE 26    CHEMICAL COMPUTING GROUP: COMPANY SNAPSHOT

FIGURE 27    PHYSIOMICS: COMPANY SNAPSHOT

FIGURE 28    EVIDERA: COMPANY SNAPSHOT

FIGURE 29    INSILICO BIOSCIENCES: COMPANY SNAPSHOT

FIGURE 30    INOSIM SOFTWARE: COMPANY SNAPSHOT

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Biosimulation Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period

Instant access to hundreds of data points and trends

Panorama del mercado de la biosimulación

Frequently Asked Questions

• What is the worth of Biosimulation market?

• What is the size of the North America Biosimulation market industry?

• What are some of the market's driving forces?

• Which are the top companies to hold the market share in Biosimulation market?

• What is the leading application of Biosimulation market?

• Which is the largest regional market for Biosimulation market?

Biosimulation Market Segment Analysis

Biosimulation Market Players

Who Should Buy? Or Key Stakeholders

Biosimulation Market Regional Analysis

Key Market Segments: Biosimulation Market

LIST OF TABLES

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

License Type

Get Sample to Email

SPEAK WITH OUR ANALYST

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

Talk to Expert

+1 (704) 266-3234

Send an Email

Contact us

Quick Links

We accept